MabVax Therapeutics Holdings Inc (NASDAQ:MBVX)

2.35
Delayed Data
As of Feb 16
 +0.0246 / +1.06%
Today’s Change
1.28
Today|||52-Week Range
10.71
+11.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.00314.2K1.3M148.1K
 
 
 
 
Depreciation And Amortization0.0012.2K21.4K96.6K
 
 
 
 
 
Operating ExpensesGross Income0.00--------
General Expenses5.8M8.7M19.4M16.7M
 
 
 
 
 
Research And Development2.0M3.5M9.6M7.8M
 
 
 
 
 
Total Operating Expenses5.8M8.7M19.4M16.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.8M-8.4M-18.1M-16.7M
 
 
 
 
 
Extraordinary Credit591.0K475.4K19.8K0.00
 
 
 
 
Interest Expense On Debt--0.000.00997.4K
 
 
Other Expenses8.0K-379.00-227.000.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.2M-7.9M-18.1M-17.7M
 
 
 
 
 
Preferred Dividend0.00-2.7M-17.9M0.00
 
 
 
Net Income-5.2M-7.9M-18.1M-17.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.2K50.1K893.9K8.1M
 
 
 
 
 
Shares To Calculate EPS Diluted25.2K50.1K893.9K8.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$207.79-$211.12-$40.40-$10.92
 
 
 
 
 
EPS Diluted-$207.79-$211.12-$40.40-$2.19